Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GCK | P35557 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8182843 | 1.00 | AKR1C3 (0.52) | AKR1C3HCAR2MAPTLMNANPSR1 | |
| SCHEMBL4606722 | 0.89 | MAPT (0.49) | AKR1C3HCAR2MAPTLMNANPSR1 | |
| SCHEMBL4606718 | 0.89 | MAPT (0.49) | AKR1C3HCAR2MAPTLMNANPSR1 | |
| SCHEMBL21327845 | 0.83 | MAPT (0.50) | HCAR2MAPTLMNANPSR1KMT2A | |
| SCHEMBL21327847 | 0.81 | NPSR1 (0.44) | HCAR2MAPTLMNANPSR1KMT2A | |
| SCHEMBL29663180 | 0.80 | MAPT (0.68) | HCAR2MAPTLMNANPSR1KMT2A | |
| SCHEMBL9116907 | 0.80 | MAPT (0.68) | HCAR2MAPTLMNANPSR1KMT2A | |
| SCHEMBL8303646 | 0.80 | HCAR2 (0.55) | HCAR2MAPTLMNANPSR1KMT2A | |
| SCHEMBL11539420 | 0.80 | HCAR2 (0.55) | HCAR2MAPTLMNANPSR1KMT2A | |
| SCHEMBL8303644 | 0.80 | HCAR2 (0.55) | HCAR2MAPTLMNANPSR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008933-A1 | UNIFORM UV-CURABLE COATINGS FOR 3D-PRINTED ORTHODONTIC DEVICES AND METHODS FOR PREPARING THE SAME | ALIGN TECHNOLOGY INC (US) | 2026-01-08 | — | — | US | claimed |
| US-20250382499-A1 | WATERBORNE COATING FORMULATION WITH POLYHEDRAL OLIGOMERIC SILSESQUIOXANE, SYNTHETIC METHOD AND APPLICATION THEREOF | NANO & ADVANCED MATERIALS INST LTD (HK) | 2025-12-18 | — | — | US | claimed |
| US-11807774-B2 | Thoroughly modified, functionalized polymeric hard coating material for coatings, methods for synthesizing the same and applications thereof | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2023-11-07 | — | — | US | claimed |
| US-11535713-B2 | Network polymers and methods of making and using same | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2022-12-27 | — | — | US | claimed |
| US-20210292482-A1 | NETWORK POLYMERS AND METHODS OF MAKING AND USING SAME | THE REGENTS OF THE UNIV OF COLORADO A BODY CORPORTATE (US) | 2021-09-23 | — | — | US | claimed |
| US-20210189173-A1 | THOROUGHLY MODIFIED, FUNCTIONALIZED POLYMERIC HARD COATING MATERIAL FOR COATINGS, METHODS FOR SYNTHESIZING THE SAME AND APPLICATIONS THEREOF | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2021-06-24 | — | — | US | claimed |
| EP-3504251-A1 | NETWORK POLYMERS AND METHODS OF MAKING AND USING SAME | The Regents of the University of Colorado, a Body Corporate (US) | 2019-07-03 | — | — | EP | claimed |
| WO-2018039331-A1 | NETWORK POLYMERS AND METHODS OF MAKING AND USING SAME | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2018-03-01 | — | — | WO | claimed |
| WO-2015108585-A2 | POLYMERIZED MICROARRAYS | NEW YORK UNIVERSITY (US) | 2015-07-23 | — | — | WO | claimed |
| US-20150111764-A1 | POLYMERIZED MICROARRAYS | NEW YORK UNIVERSITY (US) | 2015-04-23 | — | — | US | claimed |
| EP-0403159-A2 | Imidazolyl-alkenoic acids | SMITHKLINE BEECHAM CORPORATION (US) | 1990-12-19 | — | — | EP | claimed |
| JP-6073131-A | — | — | None | — | — | JP | disclosed |
| EP-3504251-B1 | NETWORK POLYMERS AND METHODS OF MAKING AND USING SAME | UNIV COLORADO REGENTS (US) | 2026-03-25 | — | — | EP | disclosed |
| US-12558458-B2 | Targeted in situ therapeutic delivery of secreted factors from stem cells for treatment of damaged tissue | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-02-24 | — | — | US | disclosed |
| US-20260022213-A1 | HYDROGELS AND METHODS OF USING THE SAME | ROWAN UNIVERSITY (US) | 2026-01-22 | — | — | US | disclosed |
| EP-0592933-A1 | Method for the preparation of thiol(meth)acrylates | RÖHM GMBH (DE) | 1994-04-20 | — | — | EP | disclosed |
| JP-H0673131-A | PRODUCTION OF SULFUR-CONTAINING TRANSPARENT POLYMER | TORAY IND INC | 1994-03-15 | — | — | JP | disclosed |
| EP-0403159-A2 | Imidazolyl-alkenoic acids | SMITHKLINE BEECHAM CORPORATION (US) | 1990-12-19 | — | — | EP | disclosed |
| EP-0044835-A1 | CATALYSED ALTERNATING COPOLYMERISATION AND PRODUCT | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1982-02-03 | — | — | EP | disclosed |
| WO-1981001289-A1 | CATALYSED ALTERNATING COPOLYMERISATION AND PRODUCT | BAMFORD C | 1981-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022213-A1 | HYDROGELS AND METHODS OF USING THE SAME | COL14A1, COL2A1, COL1A1 | AKR1C3 2804/4885HCAR2 292/4885MAPT 2335/4885 |
| US-12558458-B2 | Targeted in situ therapeutic delivery of secreted factors from stem cells for treatment of damaged tissue | CXCL12, CD44, BST2 | AKR1C3 4350/4885HCAR2 2988/4885MAPT 4528/4885 |
| US-20260008933-A1 | UNIFORM UV-CURABLE COATINGS FOR 3D-PRINTED ORTHODONTIC DEVICES AND METHODS FOR PREPARING THE SAME | MAP1LC3B, MAP1LC3A, MAP1LC3C | AKR1C3 910/4885HCAR2 2531/4885MAPT 524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.